Evidence map›Paper›PMID 26350616›Full record

ArticleNanoscale2015

Progress toward clonable inorganic nanoparticles.

Thomas W Ni, Lucian C Staicu, Richard S Nemeth, Cindi L Schwartz, David Crawford, Jeffrey D Seligman, William J Hunter, Elizabeth A H Pilon-Smits, Christopher J Ackerson

Abstract read
In one paragraph

Article in Nanoscale, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 43 citations in OpenAlex.

  1. Cloneable contrast across all biological length scales.Journal of structural biology · 2026
    Article
  2. Microbial respiration - a biomineral perspective.FEMS microbiology ecology · 2025
    Review
  3. Article
  4. Cloneable inorganic nanoparticles.Chemical communications (Cambridge, England) · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Enzyme-CatalyzedThe journal of physical chemistry. C, Nanomaterials and interfaces · 2019
    Article
  11. Elemental Sulfur Formation byFrontiers in microbiology · 2019
    Article
  12. Metalloid Reductase ofACS omega · 2018
    Article
  13. Selenium Nanoparticle Synthesized byInternational journal of molecular sciences · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Thomas W NiDepartment of Chemistry, Colorado State University, Fort Collins, CO 80523, USA. ackerson@colostate.edu.
Lucian C Staicu
Richard S Nemeth
Cindi L Schwartz
David Crawford
Jeffrey D Seligman
William J Hunter
Elizabeth A H Pilon-Smits
Christopher J Ackerson
Collins College · USColorado State University · USUniversity of Colorado System · US

Funding

A MULTI-SCALE APPROACH TO CELL STRUCTURE & FUNCTIONP41GM103431 · NIGMS · UNIVERSITY OF COLORADO · PI HOENGER, ANDREAS · 2012 to 2014
$3.1M
Clonable NanoparticlesR21EB014520 · NIBIB · COLORADO STATE UNIVERSITY · PI ACKERSON, CHRISTOPHER JEFFRIES · 2012 to 2013
$388k
NIBIB NIH HHS R21 EB014520NIGMS NIH HHS P41 GM103431NIGMS NIH HHS P41GM103431
6 · The paper itself

Abstract

Pseudomonas moraviensis stanleyae was recently isolated from the roots of the selenium (Se) hyperaccumulator plant Stanleya pinnata. This bacterium tolerates normally lethal concentrations of SeO3(2-) in liquid culture, where it also produces Se nanoparticles. Structure and cellular ultrastructure of the Se nanoparticles as determined by cellular electron tomography shows the nanoparticles as intracellular, of narrow dispersity, symmetrically irregular and without any observable membrane or structured protein shell. Protein mass spectrometry of a fractionated soluble cytosolic material with selenite reducing capability identified nitrite reductase and glutathione reductase homologues as NADPH dependent candidate enzymes for the reduction of selenite to zerovalent Se nanoparticles. In vitro experiments with commercially sourced glutathione reductase revealed that the enzyme can reduce SeO3(2-) (selenite) to Se nanoparticles in an NADPH-dependent process. The disappearance of the enzyme as determined by protein assay during nanoparticle formation suggests that glutathione reductase is associated with or possibly entombed in the nanoparticles whose formation it catalyzes. Chemically dissolving the nanoparticles releases the enzyme. The size of the nanoparticles varies with SeO3(2-) concentration, varying in size form 5 nm diameter when formed at 1.0 μM [SeO3(2-)] to 50 nm maximum diameter when formed at 100 μM [SeO3(2-)]. In aggregate, we suggest that glutathione reductase possesses the key attributes of a clonable nanoparticle system: ion reduction, nanoparticle retention and size control of the nanoparticle at the enzyme site.

Indexed as

NanoparticlesParticle SizePseudomonasSelenious AcidSeleniumSelenious AcidSelenium

Identifiers

PMID26350616
PMCPMC4785824
OpenAlexW2121506099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.